Author:
Valiev A. K.,Musaev E. R.,Sushentsov E. A.,Borzov K. A.,Aliev M. D.
Abstract
The treatment of the patients with metastatic spinal lesions is one of the most difficult problems in modern vertebrology and oncology. The experience of Russian Cancer Research Center based on the clinical analysis on 214 patients with metastatic spine disease showed the results of median survival rate overall 6 months. The mean survival rate in cases of renal cancer metastases consisted 11,2 months, breast cancer - 16,2 months, lung cancer mts - 2,1 months, prostate cancer - 17,7 months, unknown primary origin - 7,8 months. We compared our results with expected survival, scored by Tokuhashi scale. The real survival rate and expected matched only in patients with renal and lung cancer mts.
Reference11 articles.
1. Алиев М.Д. Современные подходы к хирургическому лечению метастазов злокачественных опухолей в кости/М.Д. Алиев [и др.]//Практическая онкология: избранные лекции. -СПб.: Центр ТОММ, 2004. -С. 738-748.
2. Валиев А.К. Вертебропластика в лечении больных с опухолевым поражением позвоночника: дис.... канд. мед. наук/Валиев А.К. -М., 2006. -127 с.
3. Каллистов В.Е. Метастатические опухоли позвоночника (клиника, диагностика, лечение): дис.... канд. мед. наук/Каллистов В.Е. -М., 1999. -121 с.
4. Bauer H.C. Survival after surgery for spinal and extremity metastases: prognostication in 241 patients/H.C. Bauer, R. Wedin//Acta Orthop. Scand. -1995. -Vol. 66. -P. 143-146.
5. Bayley A. A prospective study of factors predicting clinically occults spinal cord compression in patients with metastatic prostate carcinoma/A. Bayley [et al.]//Cancer. -2001. -Vol. 92. -P. 303-310.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献